Table 3.
Univariate analysis of prognostic factors affecting BCFI and OS, The Ruijin cohort.
| Characteristics | P value | |
|---|---|---|
| BCFI | OS | |
| Age (< 40 vs. 40–49 vs.50–70 vs. > 70) | 0.053 | 0.001 |
| Menstrual status (Pre/Peri- vs. Post-) | 0.335 | 0.016 |
| Residence (Large metropolitan vs. Metropolitan vs. Urban vs. Rural) | 0.596 | 0.875 |
| CCI (0 vs. 1–2 vs. 3 +) | 0.173 | 0.756 |
| Education level (Post-graduated vs. Degree vs. High school vs. Middle school) | 0.062 | 0.127 |
| BMI (< 25 vs. 25–30 vs. ≥ 30) | 0.389 | 0.220 |
| Histology type (IDC vs. Non-IDC) | 0.304 | 0.695 |
| Tumor size (≤ 2.0 cm vs. > 2.0 cm) | < 0.001 | < 0.001 |
| ALN status (Negative vs. Positive) | < 0.001 | < 0.001 |
| Tumor stage (I vs. II vs. III) | < 0.001 | < 0.001 |
| Histological grade (I vs. II vs. III) | < 0.001 | 0.050 |
| LVI (Negative vs. Positive) | < 0.001 | 0.003 |
| ER (Negative vs. Positive) | < 0.001 | < 0.001 |
| PR (Negative vs. Positive) | < 0.001 | < 0.001 |
| HER2 (Negative vs. Positive) | 0.089 | 0.987 |
| Ki67 (< 14% vs. ≥ 14%) | < 0.001 | 0.001 |
| Molecular subtype (HR + /HER2- vs. HER2 + vs. TNBC) | 0.001 | 0.001 |
| Chemotherapy (No vs. Yes) | 0.001 | 0.912 |
| Radiation therapy (No vs. Yes) | 0.002 | 0.177 |
| Time to surgery (≤ 1w vs. 1–2 w vs. > 2w) | 0.088 | 0.002 |